Physician profile
Jonathan Garrison
NPI 1427018050
$1,088.82
in general payments reported to CMS, 2019-2025
13 companies · $77.21 in 2025
The $77.21 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $96.46 · 2021: $211 · 2022: $187 · 2023: $120 · 2024: $226 · 2025: $77.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $448.28 | 2019-2025 | Spravato |
| Ironshore Pharmaceuticals INC. | $148.49 | 2019-2021 | |
| Corium, LLC | $125.60 | 2022-2024 | Azstarys |
| Neurocrine Biosciences, INC. | $80.77 | 2020-2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $69.78 | 2019-2025 | Abilify Maintena, Rexulti |
| Supernus Pharmaceuticals, INC. | $59.60 | 2021-2024 | Qelbree |
| Lundbeck LLC | $32.12 | 2024 | Rexulti |
| Vertical Pharmaceuticals, LLC | $27.98 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.00 | 2020-2021 | |
| Shire North American Group INC | $19.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $18.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.00 | 2024 | |
| Tris Pharma INC | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Garrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.